Suppression of S-phase kinase-associated protein 2 induces apoptosis and inhibits tumor growth in human laryngeal cancer

ORL

Volumn 72, Issue 4, 2010, Pages 205-214

  Liu, Jiangtao ^a   Tan, Lijun ^b   Li, Huijun ^b   Wang, Qiwei ^b   Ji, Wenyue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Laryngeal carcinoma; Lentivirus; RNA interference; S phase kinase associated protein 2

Indexed keywords

PROTEIN P27; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LENTIVIRINAE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MICE; POLYMERASE CHAIN REACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED;

EID: 77954917651     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000314689     Document Type: Article

References (33)

1. Guan Z, Wang XR, Zhu XF, Huang XF, Xu J, Wang LH, Wan XB, Long ZJ, Liu JN, Feng GK, Huang W, Zeng YX, Chen FJ, Liu Q: Aurora- A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res 2007; 67: 10436-10444.
2. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A: The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001; 3: 321-324.
3. Zhang H, Kobayashi R, Galaktionov K, Beach D: P19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 1995; 82: 915-925.
4. Yokoi S, Yasui K, Iizasa T, Takahashi T, Fujisawa T, Inazawa J: Down-regulation of SKP2 induces apoptosis in lung-cancer cells. Cancer Sci 2003; 94: 344-349.
5. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1: 193-199.
6. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M: S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. Oncol Rep 2003; 10: 321-325.
7. Kudo Y, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T: Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation. Mol Cancer Ther 2005; 4: 471-476.
8. Ma XM, Liu JH, Guo JW, Liu Y, Zuo LF: Correlation of Skp2 expression in gastric carcinoma to expression of P27 and PTEN (in Chinese). Ai Zheng 2006; 25: 56-61.
9. Kamata Y, Watanabe J, Nishimura Y, Arai T, Kawaguchi M, Hattori M, Obokata A, Kuramoto H: High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma. J Cancer Res Clin Oncol 2005; 131: 591-596.
10. Takanami I: The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer. Oncol Rep 2005; 13: 727-731.
11. Jiang F, Caraway NP, Li R, Katz RL: RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene 2005; 24: 3409-3418.
12. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, Shirane M, Tsunematsu R, Tsukiyama T, Ishida N, Kitagawa M, Hatakeyama S: Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19: 2069-2081.
13. Hannon GJ: RNA interference. Nature 2002; 418: 244-251.
14. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans . Nature 1998; 391: 806-811. (Pubitemid 28099681)
15. McManus MT, Sharp PA: Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002; 3: 737-747.
16. Nishitsuji H, Ikeda T, Miyoshi H, Ohashi T, Kannagi M, Masuda T: Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of hiv-1 on human cells including primary non-dividing cells. Microbes Infect 2004; 6: 76-85.
17. Liu CM, Liu DP, Dong WJ, Liang CC: Retrovirus vector-mediated stable gene silencing in human cell. Biochem Biophys Res Commun 2004; 313: 716-720.
18. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
19. Shin JJ, Katayama T, Michaud WA, Rocco JW: Short hairpin RNA system to inhibit human p16 in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004; 130: 68-73.
20. Gao LF, Xu DQ, Wen LJ, Zhang XY, Shao YT, Zhao XJ: Inhibition of STAT3 expression by siRNA suppresses growth and induces apoptosis in laryngeal cancer cells. Acta Pharmacol Sin 2005; 26: 377-383.
21. Sun Y, Liu M, Yang B, Lu J, Li B: Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene. Cancer Invest 2008; 26: 984-989.
22. Sumimoto H, Hirata K, Yamagata S, Miyoshi H, Miyagishi M, Taira K, Kawakami Y: Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi. Int J Cancer 2006; 118: 472-476.
23. Lee SH, McCormick F: Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. J Mol Med 2005; 83: 296-307.
24. Lu XY, Li XM: Expression of S-phase kinase associated protein 2 in laryngeal carcinoma and its molecular mechanisms involved in regulation of proliferation and apoptosis of Hep-2 cells (in Chinese). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2009; 44: 681-686.
25. Wirbelauer C, Sutterluty H, Blondel M, Gstaiger M, Peter M, Reymond F, Krek W: The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J 2000; 19: 5362-5375.
26. Morimoto M, Nishida T, Honda R, Yasuda H: Modification of cullin-1 by ubiquitin-like protein Nedd8 enhances the activity of SCF(skp2) toward p27(kip1). Biochem Biophys Res Commun 2000; 270: 1093-1096.
27. Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI: Degradation of p57Kip2 mediated by scfskp2-dependent ubiquitylation. Proc Natl Acad Sci USA 2003; 100: 10231-10236.
28. Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, Hershko A: Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem 2003; 278: 25752-25757.
29. Shapira M, Ben-Izhak O, Linn S, Futerman B, Minkov I, Hershko DD: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer 2005; 103: 1336-1346.
30. Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M: Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Oncol Rep 2006; 15: 765-771.
31. Traub F, Mengel M, Luck HJ, Kreipe HH, von Wasielewski R: Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat 2006; 99: 185-191.
32. Dowen SE, Scott A, Mukherjee G, Stanley MA: Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression. Int J Cancer 2003; 105: 326-330.
33. Oliveira AM, Okuno SH, Nascimento AG, Lloyd RV: Skp2 protein expression in soft tissue sarcomas. J Clin Oncol 2003; 21: 722-727.